New SEC Form D filing
MBQ PHARMA INC., 2026-08-14
A new SEC Form D private-offering notice from San Juan, PR, an undisclosed offering target in Biotech. The source filing is one click away.
What this filing says
clinical stage biopharmaceutical company in Puerto Rico developing cancer and autoimmune drug candidates, including the Rac/Cdc42 inhibitor MBQ-167
Filed 5 days agoFiled to raise Undisclosed The filer declared an indefinite offering amount; we say so instead of inventing a number.First money in 2018-06-30Raised so far $1,530,000HQ (as filed) San Juan, PRSector Biotech web-verified against the company’s own siteStage (inferred) SeedCall status Late filing
Source linked the Form D on EDGAR↗Website verified mbqpharma.com↗Named in the filing 6 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Also filed for this raise
every source Form D behind this opportunityOther Form D filings from the same week
each with its own page and its own EDGAR source- Lotus Intelligence LLC, 2026-06-15, $700K, Guaynabo, PR
- Andira Medicine Inc., 2026-08-18, $100K, North Vancouver, BC, Canada
- Mielodia LLC, 2026-06-12, $200K, San Juan, PR
- EnduraFAST Inc., 2026-08-17, $500K, The Villages, FL
- Green Acres R&D Processors LLC, 2026-06-08, $500K, San Juan, PR
- Georgiamune, Inc., 2026-08-17, $131.9M, Gaithersburg, MD
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.